In terms of market performance, Ginkgo Bioworks Holdings Inc had a fairly uneven. The highest value for the stock in the past year was $40.40 on 05/14/24, and the lowest value was recorded at $5.00 on 04/04/25.
52-week price history of DNA Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Ginkgo Bioworks Holdings Inc’s current trading price is -81.68% away from its 52-week high, while its distance from the 52-week low is 48.00%. The stock’s price range during the 52-week period has remained between $5.00 and $40.40. In the Healthcare sector, the company’s shares saw a trading volume of around 1.78 million for the day, which was evidently higher than the average daily volume of 1.59 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Ginkgo Bioworks Holdings Inc (DNA) has experienced a quarterly decline of -54.77% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 430.54M and boasts a workforce of 834 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.32, with a change in price of -3.63. Similarly, Ginkgo Bioworks Holdings Inc recorded 1,560,226 in trading volume during the last 100 days, posting a change of -32.91%.
Examining DNA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for DNA stands at 0.65. Similarly, the long-term debt-to-equity ratio is also 0.61.
DNA Stock Stochastic Average
Ginkgo Bioworks Holdings Inc’s raw stochastic average for the past 50 days is presently 45.89%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 56.57%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 45.38% and 47.86%, respectively.
DNA Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded a decrease of -24.64%. However, over the last six months, the performance has been stronger by -4.52%. The price of DNA increased 15.44% over the last 30 days. And in the last five days, it has surged by 0.41%.
